openPR Logo
Press release

Cancer Metabolism-Based Therapeutics Market to Reach USD 6.43 Billion by 2034

12-05-2025 11:32 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Cancer Metabolism-Based Therapeutics Market

Cancer Metabolism-Based Therapeutics Market

Pune, India - December 2025 - The global Cancer Metabolism-Based Therapeutics Market, valued at USD 1.98 billion in 2024, is expected to reach USD 6.43 billion by 2034, growing at a powerful 12.6% CAGR (2025-2034), according to Exactitude Consultancy. Increasing research into tumor metabolic pathways and rising development of therapies that disrupt cancer cell energy sources are driving market expansion.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73161

Market Summary
The Cancer Metabolism-Based Therapeutics Market is witnessing strong growth as drug developers increasingly target altered metabolic pathways that fuel tumor progression, metastasis, and treatment resistance. Key pathways such as glycolysis (Warburg effect), glutaminolysis, lipid metabolism, mitochondrial oxidative phosphorylation, and redox regulation are at the forefront of therapeutic innovation.

Pharmaceutical companies are advancing small-molecule inhibitors, metabolic enzyme blockers, and combination therapies to improve treatment outcomes. Promising clinical pipelines include agents targeting IDH1/2, glutaminase (GLS), LDH-A, FASN, and mTOR pathways. North America dominates the market due to strong oncology R&D, while Asia-Pacific is the fastest-growing region, driven by increasing cancer incidence and investment in precision oncology.

Key Takeaways
• 2024 Market Size: USD 1.98 Billion
• 2034 Forecast: USD 6.43 Billion
• CAGR: 12.6% (2025-2034)
• Strong clinical pipeline targeting metabolic vulnerabilities in tumors
• Increasing use of combination therapies with immuno-oncology drugs
• Rising investment in metabolic pathway biomarkers & diagnostics

Explore Full Report here:
https://exactitudeconsultancy.com/reports/73161/cancer-metabolism-based-therapeutics-market

Market Drivers
• Growing understanding of cancer metabolism and metabolic reprogramming
• Development of inhibitors for key metabolic enzymes (IDH, GLS, FASN, etc.)
• Rising adoption of precision oncology and biomarker-driven therapies
• Increasing cancer incidence, especially solid tumors and hematologic cancers
• Strong collaborations between biotech firms, academic centers, and pharma

Segmentation Snapshot
By Therapy Type
• Metabolic Enzyme Inhibitors
• Small-Molecule Targeted Therapies
• Immunometabolism Modulators
• Combination Therapies

By Target Pathway
• Glycolysis & Warburg Effect
• Glutamine Metabolism
• Lipid Metabolism
• Redox Pathways
• Mitochondrial Metabolism

By Cancer Type
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Leukemia
• Pancreatic Cancer
• Others

By End User
• Hospitals
• Cancer Treatment Centers
• Research & Academic Institutes

By Region
• North America (Largest Share)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73161

Recent Developments
• Multiple GLS and IDH inhibitors advancing into Phase II/III trials.
• Combination regimens integrating metabolic inhibitors with checkpoint inhibitors showing strong early data.
• Research momentum growing in immunometabolism to enhance T-cell activity.

Expert Quote - Irfan Tamboli, Business Development Executive
"Targeting cancer metabolism is emerging as one of the most promising approaches in oncology. As we decode metabolic dependencies in tumors, next-generation therapies have the potential to deliver deeper, more durable responses for patients."

Conclusion
The Cancer Metabolism-Based Therapeutics Market will continue accelerating through 2034 as precision oncology, metabolic biomarkers, and targeted enzyme inhibitors reshape cancer treatment strategies. Companies pioneering metabolic drug development and combination approaches will lead the next wave of therapeutic breakthroughs.

This report is also available in the following languages : Japanese (がん代謝に基づく治療薬市場), Korean (암 대사 기반 치료제 시장), Chinese (基于癌症代谢的治疗市场), French (Marché des thérapies basées sur le métabolisme du cancer), German (Markt für auf dem Krebsstoffwechsel basierende Therapeutika), and Italian (Mercato delle terapie basate sul metabolismo del cancro), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73161

Our More Reports:

Drug Bioavailability Enhancement Market
https://exactitudeconsultancy.com/reports/73151/drug-bioavailability-enhancement-market

Respiratory Disorders Market
https://exactitudeconsultancy.com/reports/73153/respiratory-disorders-market

Cancer Stem Cell Therapies Market
https://exactitudeconsultancy.com/reports/73155/cancer-stem-cell-therapies-market

Modular Pharmaceutical Construction Market
https://exactitudeconsultancy.com/reports/73157/modular-pharmaceutical-construction-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Metabolism-Based Therapeutics Market to Reach USD 6.43 Billion by 2034 here

News-ID: 4302489 • Views:

More Releases from Exactitude Consultancy

Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitation and Infrastructure Projects
Cold Planer Market Sees Consistent Growth Supported by Global Road Rehabilitatio …
The global cold planer market is experiencing steady growth as governments and private contractors increase spending on road rehabilitation, resurfacing, and infrastructure modernization. Cold planers, also known as milling machines, are widely used to remove damaged asphalt and concrete surfaces efficiently, supporting sustainable road construction practices. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68250 Key Market Highlights • Increasing focus on road maintenance and resurfacing projects • Growing demand for efficient and precision milling
Credit Management Software Market Accelerates as Organizations Focus on Risk Mitigation and Cash Flow Optimization
Credit Management Software Market Accelerates as Organizations Focus on Risk Mit …
The global credit management software market is witnessing robust growth as organizations across industries adopt digital solutions to manage credit risk, improve receivables performance, and strengthen financial controls. Credit management software enables businesses to automate credit scoring, monitor customer creditworthiness, and streamline collections processes. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68248 Key Market Highlights • Growing adoption of automated credit risk assessment tools • Increasing focus on working capital and cash flow management • Integration
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Operators Strengthen Network Security
Session Border Controller Market Expands Rapidly as Enterprises and Telecom Oper …
The global session border controller (SBC) market is experiencing strong growth as telecom operators and enterprises increasingly deploy SBC solutions to secure, manage, and optimize real-time IP communications. SBCs play a critical role in protecting voice over IP (VoIP), unified communications (UC), and multimedia sessions from cyber threats while ensuring interoperability and quality of service. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68246 Key Market Highlights • Growing adoption of VoIP and
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Traction Amid Global Decarbonization Efforts
Biofuel Market Including E-Methane and Sustainable Aviation Fuel Gains Strong Tr …
The global biofuel market, encompassing e-methane, sustainable aviation fuel (SAF), and other advanced biofuels, is witnessing robust growth as governments and industries intensify efforts to reduce carbon emissions and transition toward cleaner energy sources. These fuels play a critical role in achieving net-zero targets while enabling decarbonization of hard-to-abate sectors such as aviation, shipping, and heavy transportation. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/68244 Key Market Highlights • Rapid growth of

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For